Annual Report 2025: Expanding to more states, launching advance provision, and preparing for the future
Reflecting on 2024 from today’s vantage point is sobering. The year ended with a presidential administration hostile to reproductive rights poised to return to office and a coordinated opposition prepared with a playbook to further restrict abortion access across the United States. Online, paid political ads, adoption of AI, and major changes to search algorithms made it even harder for people in the United States to find accurate information about essential healthcare, including reproductive and abortion care.
It’s tempting to view 2024 solely as the on-ramp to the chaos of 2025. But at carafem, we’re telling a different story.
2024 wasn’t a year of waiting and worrying—it was a year of growth, innovation, and bold preparation for what’s ahead. Together, we made meaningful strides.
We expanded access. carafem began serving clients in Michigan and New York, bringing our footprint at the end of 2024 to 17 states plus Washington, D.C. We also extended our medication abortion care program to support people with pregnancies up to 12 weeks.
We reduced financial barriers. We launched a sliding scale for fees and increased Maryland and Illinois Medicaid coverage for telehealth abortion care. These changes have helped us serve twice as many low-income clients, and we've seen a significant increase in both states since enhanced access to Medicaid coverage began.
We pioneered new options. In late 2024, we launched “abortion pills for future use,” expanding access to essential medications even before someone is pregnant. Now available in most states we serve, demand for this option continues to grow.
We got louder. Abortion care must be visible to be accessible. In 2024, we refreshed our brand to reflect our bold, values-driven approach, ramped up our marketing to reach people traveling for care, and advertised to over 100 million people. Our efforts in NY at Times Square were recognized with a Gold Anthem Award.
We invested in the future. carafem is actively fundraising to keep care affordable for the people who need us most, while working toward long-term sustainability through operational efficiency and small, high-performing healthcare teams. Your support plays a critical role in making this possible—especially as we rise to meet the needs of today's shifting landscape.
Looking back, 2024 wasn’t just a turning point—it was a test of values, vision, and will. At carafem, we responded not with fear, but with forward motion. We doubled down on our mission: to reimagine reproductive healthcare in the United States with compassion, clarity, and courage.
